ArticleAmerican journal of translational research2024
Burden of cardiovascular disease attributable to lead exposure in China: a comprehensive analysis of data from 1990 to 2019.
Article in American journal of translational research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo analyze the burden of cardiovascular disease (CVD) caused by lead pollution exposure in China from 1990 to 2019.
methodsUtilizing data from the Global Burden of Disease 2019 (GBD 2019), this research examines the changes in the number of CVD deaths, deaths rates, disability-adjusted life years (DALYs) and DALY rates, as well as their age-normalization rates, due to lead pollution exposure in China from 1990 to 2019. Joinpoint was used to estimate average annual percentage of change (AAPC) and reflect the time change trend of the burden of CVD caused by lead pollution exposure in China, the world and different socio-demographic index (SDI) regions.
resultsThe age-standardized mortality rate and age-standardized DALY rate showed a decreasing trend in China from 1990 to 2019, with an average annual decrease of -1.17% (95% confidence interval (CI): -3.49~-3.14, P<0.05) and -1.90% (95% CI: -2.04~-1.75, P<0.05), respectively. In 2019, age-standardized CVD mortality and DALY rates attributed to lead exposure in China were higher than those in the global, high-SDI, medium-high SDI and moderate SDI regions. In 2019, 5.94% of CVD deaths in China were caused by lead exposure. Compared to 1990, the number of attributable deaths and mortality increased by 0.73% and 0.44%, respectively, and the attributable DALY and DALY rates increased by 30.04% and 8.22%, respectively. From 1990 to 2019, the mortality rate and DALY rate of males were higher than those of females, and the mortality rate and DALY rate increased with the increase of age, reaching the highest in the age group of 70 years and above.
conclusionIn 2019, the standardized death rate of CVD and the standardized DALY rate attributed to lead pollution exposure in China were higher than those in the global regions with high SDI, medium-high SDI and medium SDI. The findings highlight demographic disparities in CVD deaths and DALYs attributable to lead exposure, with males and the elderly identified as high-risk groups.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.